We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Protherics | LSE:PTI | London | Ordinary Share | GB0007029209 | ORD 2P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 45.00 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 45.00 | GBX |
Protherics (PTI) Share Charts1 Year Protherics Chart |
|
1 Month Protherics Chart |
Intraday Protherics Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 16/7/2009 | 20:01 | It's all good news at Protherics. | 8,420 |
| 15/3/2008 | 10:27 | OVERSOLD | 5 |
| 01/1/2008 | 10:50 | PTI Protherics at Ј4 party organization | 372 |
| 22/1/2004 | 11:01 | Live on Talk! CEO and FD of Protherics Thu 22nd Jan 11am | 3 |
| 20/6/2003 | 10:58 | PROTHERICS- MOVES TO YEAR HIGH UNDER THE SPECULATION OF THE NEWS LETTER | 1 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 07/10/2008 19:27 by gnnmartin My guess is that a fair number of people bought into PTI hoping for a cash bid. They just want a return and out, so they are pulling the price down. On the other side, BTG had had a strong run up from 80p to 240p, and there were a lot of people ready to take profits. And in this market, once people start taking profits, you start hitting stop losses, and the share goes on going down.If PTI and BTG called the whole thing off, I see no reason why PTI shouldn't sink to the price it had before takeover rumours took it up, and then lower still because the market is dire, and nobody like confusion, and anyhow most other things have fallen since then. And again, if PTI and BTG call the whole thing off I don't expect BTG to bounce back. Their bull run has been broken, the domino effect of investors 'protecting profits' (or cutting losses) could well drive the share price further on down. Rational analysis may be trumped by simple fear. Nigel Martin |
Posted at 01/10/2008 10:52 by fhmktg This received this morning from Nick Staples at PTI, in prompt resonse to a query from me as to whether the company was reviewing the merger in light of curret market conditions.Thank you for your enquiry. The recommended offer is for a share exchange ratio that gives us a ~40% stake in the combined entity. This ratio was calculated as you know at a share price of 60p for Protherics, almost a 100% premium to where we were trading prior to announcing M&A interest. We believe the merger enhances the prospects for both companies, both financially and in terms of upside and risk mitigation. Both parties approached their major shareholders for their consent to a merger prior to announcement and the share price has fallen since on only relatively small volumes. We believe the focus should be on the stake in the enlarged company at this stage, given the strong rationale for the merger and the volatility in the markets. Regards Nick |
Posted at 25/9/2008 19:10 by mre bargainbob, given that the BTG/PTI prices are now in sync with the offer price it appears to me that this is reckoned to be a done deal. The high R&D is what's creating the PTI losses and the new combined company has a plan to reduce that. I think it's now more likely that someone will come in for BTG/PTI combined at sometime in the near future. But who knows? |
Posted at 25/9/2008 18:43 by mre The PTI share price is now around 45p compared with around 30p before the news was announced on "approaches from a number of parties". So have we really got that much to complain about? Of course 45p may not be the bottom but the BTG share price would have to be around 100p before PTI holders are back to square one.Just a thought to cheer up any PTI holders feeling a bit let down (like me!). |
Posted at 25/9/2008 13:58 by gnnmartin I reluctantly sold my PTI shares. The problem I see with the BTG bid is that BTG rose from about 85p to 240p in the 6 months to September. While the rise would look justified on fundamentals in normal market conditions, in the current turmoil BTG looked ripe for a setback, and the bid for PTI seems to be the trigger. I guess BTG has been weak since the bid because big PTI shareholders have been selling BTG short to lock in their gain. The two shares look to be trading roughly in line with the proposed scheme at the moment. Any further weakness in BTG relative to PTI might imply a competing interest. The next few weeks up to the 10th Nov. could prove turbulent.Nigel Martin PS. the merger reflects the ratio of the share prices of PTI and BTG at their recent lows, so looks fair to PTI and is good news for anyone who was not hoping for a cash bid. If the market does drive the combined company down to their lows again, they will be a screaming buy for anyone who (unlike me) has money to invest. But that goes for a number of companies at the moment. |
Posted at 24/9/2008 09:19 by devbod I wondered about someone coming out with an all cash spoiler for the deal but the PTI share price has been trading lower than the 0.291 multiple would suggest implying there is concern the deal may not happen at all. |
Posted at 18/9/2008 18:02 by devbod The directors awarded themselves options a few months ago at 2p a share. They'll at least get pro-rata compensation with BTG options and at most 58p (60p-2p) a share cash. I just checked the announcement but it says that the options are included in the 'Scheme' but its not clear how the compensation will be doen other than it will be 'appropriate'.Who gets what job is described in the RNS, there's a lot of detail there if you scroll down past the standard disclaimers. Although the share price of both companies prior to leaks implies PTI got by far the better half of the deal I'm not happy with the actions of PTI's directors. Cytofab phase II completion in December and Voraxase news could easily have driven PTIs share price back closer to former levels. With any faith in their products and a little less interest in their own pockets PTIs shareholders might have been better served. |
Posted at 18/9/2008 10:02 by baht BTG down _ Obviously as this is usually what happens. The Buyer share price falls and the Target share price rises. This does not look like a great deal for PTI so why have the board given their blessing. Perception is that BTG would like to get their hands on PTI's "cash in bank". Will AZN step in with counter bid I would hope so but am not confident. If this were the case why would the Board back the BTG deal. Perhaps the new company is already considering a reversion sale to AZN of their loyalty deal. This will finance the BTG new co for even longer and take AZN out of the running as a buyer competitor. Just a couple of thoughts! |
Posted at 15/8/2008 19:25 by mre MFmartinfrench - I agree, but it has to be better than looking at the monitor with a PTI share price of 29p!!! The worst that can happen is that no bid is successful and we end up back at 29p. That isn't a very nice prospect but it doesn't change the potential of PTI. The interested parties must have some belief in PTI's potential otherwise they wouldn't be showing interest. The current share price gives us a market cap of less than 200MM - for the likes of AZN this is small change and an offer of 300-400MM doesn't sound unlikely (especially given the milestone and royalty payments they would have to make if Cytofab progresses successfully). Let's hope we don't have to wait too long to find out. Regards, MrE |
Posted at 15/8/2008 14:31 by mre I was interested to note that the PTI share price spiked temporarily on 30th July the day after there was a press release on a study of angiotensin receptor blockers. Extract as follows: " People taking the drugs, known as angiotensin receptor blockers, or ARBs, had a 35-40 percent lower risk of developing Alzheimer's disease and similar neurodegenerative disorders, according to medical records of more than 5 million patients".Now 2 weeks later we have a number of parties interested in buying PTI. Coincidence? I wouldn't be too sure given PTI's work on angiotensin vaccine for hypertension. It may certainly be a contributory factor to the sudden interest? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
